Engineering the future of health

Three staff at Octane Biotech Inc. having a conversation
Dr. Lauren Flynn, Dr. Tim Smith (Octane) and Dr. Brian Amsden

Chemical engineers at Queen’s are working with Octane Biotech Inc., a leader in regenerative medicine, to develop a platform for engineering tissue that will improve orthopedic reconstruction. Bringing together expertise in stem cell isolation and culture with the development of a sophisticated polymer support for cell-growth, their work holds the potential to create a minimally invasive method for producing tissue for bone and cartilage replacement.

To learn more about Octane Biotech Inc., visit: